Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 618-523-3 | CAS number: 61461-61-8
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin irritation / corrosion
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Eye irritation
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not irritating)
Additional information
There are substantial in vivo animal data on all industrially applied enzyme classes, as well as in vitro data performed before formal validation, for skin irritancy. These data document that enzymes are not irritating, with the exception of proteases. Transaminase is not a protease. Non-proteases lack the potential to be skin irritants but proteases show a range of effects from no irritation to moderate irritation. It is, however, only the most concentrated and reactive samples which show an effect which is transient in nature and commonly is classified as mild irritation. This is also the outcome of clinical investigations, confirming that enzymes at the product use concentration, even with exaggerated exposures, do not give rise to any occupational or consumer risk of skin irritation. Given the above, in vitro irritation testing is not considered to add any scientific value nor lead to a change in the classification adopted from existing data (in-house industrial data).*
*Enzymes REACH Consortium, ERC Data waiving argumentation for technical enzymes
Justification for selection of eye irritation endpoint:
There are substantial in vivo animal data on all industrially applied enzyme classes, as well as in vitro data performed before formal validation, for eye irritancy. These data document that enzymes are not irritating, with the exception of proteases. Transaminase is not a protease. Non-proteases lack the potential to be eye irritants but proteases show a range of effects from no irritation to moderate irritation. It is, however, only the most concentrated and reactive samples which show an effect which is transient in nature and commonly is classified as mild irritation. This is also the outcome of clinical investigations, confirming that enzymes at the product use concentration, even with exaggerated exposures, do not give rise to any occupational or consumer risk of eye irritation. Given the above, in vitro irritation testing is not considered to add any scientific value nor lead to a change in the classification adopted from existing data (in-house industrial data).*
*Enzymes REACH Consortium, ERC Data waiving argumentation for technical enzymes
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
